PiggyBac as a novel vector in cancer gene therapy: Current perspective

Cancer Gene Therapy

Volumn 23, Issue 2-3, 2016, Pages 45-47

  Mirzaei, H ^a   Sahebkar, A ^a   Jaafari, M R ^a   Hadjati, J ^b   Javanmard, S H ^c   Mirzaei, H R ^b   Salehi, R ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR; TRANSPOSON;

ARTICLE; CANCER GENE THERAPY; DNA INTEGRATION; DNA ISOLATION; DNA TRANSPOSITION; GENE VECTOR; GENETIC ENGINEERING; GENOME; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PIGGYBAC TRANSPOSON; PRIORITY JOURNAL; STABLE EXPRESSION; TRANSPOSON; ANIMAL; GENE THERAPY; GENE TRANSFER; GENETICS; LEPIDOPTERA; MOUSE; NEOPLASMS; PROCEDURES; TRENDS;

ANIMALS; DNA TRANSPOSABLE ELEMENTS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LEPIDOPTERA; MICE; NEOPLASMS;

EID: 84953439446     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2015.68     Document Type: Article

References (10)

1. Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. Non-viral vectors for gene-based therapy. Nat Rev Genet 2014; 15: 541-555.
2. Workenhe ST, Mossman KL. Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies. Mol Ther 2014; 22: 251-256.
3. Bahrambeigi V, Ahmadi N, Moisyadi S, Urschitz J, Salehi R, Haghjooy Javanmard S. PhiC31/PiggyBac modified stromal stem cells: effect of interferon gamma and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma. Mol Cancer 2014; 13: 255.
4. Bahrambeigi V, Ahmadi N, Salehi R, Javanmard SH. Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation. Immunol Invest 2015; 44: 216-236.
5. Li X, Burnight ER, Cooney AL, Malani N, Brady T, Sander JD et al. PiggyBac transposase tools for genome engineering. Proc Natl Acad Sci 2013; 110: E2279-E2287.
6. Wilson MH, Coates CJ, George AL Jr. PiggyBac transposon-mediated gene transfer in human cells. Mol Ther 2007; 15: 139-145.
7. Saridey SK, Liu L, Doherty JE, Kaja A, Galvan DL, Fletcher BS et al. PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol Ther 2009; 17: 2115-2120.
8. Ding S, Wu X, Li G, Han M, Zhuang Y, Xu T. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 2005; 122: 473-483.
9. Nakazawa Y, Huye LE, Salsman VS, Leen AM, Ahmed N, Rollins L et al. PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther 2011; 19: 2133-2143.
10. Kang Y, Zhang X, Jiang W, Wu C, Chen C, Zheng Y et al. Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine. BMC Cancer 2009; 9: 126.